Metagenomics Market Synopsis

Metagenomics Market Size Was Valued at USD 2.05 Billion in 2023, and is Projected to Reach USD 6.31 Million by 2032, Growing at a CAGR of 13.3% From 2024-2032.

The global metagenomics market is a rapidly expanding sector within the broader biotechnology industry, primarily driven by advancements in DNA sequencing technologies and bioinformatics tools. Metagenomics involves the study of genetic material recovered directly from environmental samples, providing comprehensive insights into the microbial communities present in various ecosystems. This field has revolutionized our understanding of microbial diversity, ecology, and the functional capabilities of microbial consortia in natural environments. As such, the market for metagenomics encompasses a range of products and services, including sequencing platforms, software solutions, reagents, and consumables, along with specialized analytical services.

• The vital role of the metagenomics market in the overall ecosystem is multifaceted. Firstly, it enables the identification and characterization of previously unknown microorganisms, which can lead to the discovery of novel genes, enzymes, and bioactive compounds with significant industrial and pharmaceutical applications. For instance, enzymes identified through metagenomic studies are being utilized in various sectors, including agriculture, food processing, and biofuel production, thereby driving innovation and efficiency in these industries. Additionally, metagenomics plays a crucial role in environmental monitoring and bioremediation efforts by providing detailed insights into microbial community dynamics and their responses to pollutants.
• Moreover, the benefits of the metagenomics market extend to human health and disease management. Metagenomic approaches are increasingly being used to study the human microbiome, revealing its critical influence on health, disease, and therapeutic outcomes. This has paved the way for advancements in personalized medicine, where treatments can be tailored based on an individual's unique microbiome composition. For example, gut microbiome analysis is being used to develop probiotics and dietary interventions that promote health and prevent diseases such as obesity, diabetes, and inflammatory bowel disease. Additionally, metagenomics is instrumental in tracking and controlling infectious disease outbreaks by enabling rapid identification of pathogens and their resistance genes.
• In the industrial context, the metagenomics market enhances the efficiency of various biotechnological processes. Industrial microbiology, waste management, and synthetic biology are just a few areas where metagenomic insights are applied to optimize processes and develop new bioproducts. By understanding microbial interactions and functions at a community level, industries can harness these insights to innovate and improve product yields, reduce costs, and implement sustainable practices. Overall, the global metagenomics market not only contributes to scientific and medical advancements but also drives economic growth and sustainability across multiple industries, highlighting its integral role in the modern ecosystem.

Metagenomics Market Trend Analysis

Rising Application of Next-Generation Sequencing (NGS) Technologies

• The integration of Next-Generation Sequencing (NGS) technologies in metagenomics is revolutionizing the field by enabling high-throughput, precise, and comprehensive analysis of microbial communities. NGS technologies, such as Illumina sequencing and Oxford Nanopore sequencing, provide unparalleled depth and resolution, allowing researchers to identify and quantify microbial species with high accuracy. This advancement is crucial for understanding the complex dynamics of microbial ecosystems in various environments, including human health, agriculture, and environmental sciences.
• One of the primary benefits of NGS in metagenomics is its ability to detect low-abundance microorganisms that were previously undetectable with traditional methods. This sensitivity is particularly valuable in clinical diagnostics, where identifying pathogenic microbes at an early stage can lead to more effective treatments and better patient outcomes. Additionally, NGS allows for the simultaneous analysis of thousands of samples, significantly reducing the time and cost associated with large-scale metagenomic studies.
• Furthermore, the continuous development of NGS platforms and the reduction in sequencing costs are making these technologies more accessible to a broader range of researchers and institutions. The advent of portable and real-time sequencing devices, such as the MinION by Oxford Nanopore, is expanding the applications of NGS in field-based research, enabling on-site metagenomic analyses. This trend is expected to drive significant growth in the global metagenomics market, as more sectors recognize the potential of NGS to uncover valuable insights into microbial diversity and function.

Expansion of Bioinformatics Tools and Databases

• The rapid growth of metagenomic data has necessitated the development and expansion of advanced bioinformatics tools and databases to manage, analyze, and interpret the vast amounts of information generated. These tools are essential for the accurate assembly, annotation, and comparison of metagenomic sequences, facilitating the identification of novel microbial genes, pathways, and interactions. Key software platforms, such as QIIME, MetaPhlAn, and MEGAHIT, have become integral to metagenomic research, providing robust and scalable solutions for data analysis.
• One of the significant trends in bioinformatics for metagenomics is the emphasis on improving computational efficiency and scalability. As sequencing technologies produce larger datasets, bioinformatics tools must evolve to handle these volumes without compromising accuracy. Innovations in machine learning and artificial intelligence (AI) are being incorporated into bioinformatics workflows to enhance predictive modeling, pattern recognition, and functional annotation of metagenomic data. These advancements are crucial for transforming raw sequence data into meaningful biological insights.
• Additionally, the establishment of comprehensive and publicly accessible metagenomic databases is crucial for advancing the field. Databases such as MG-RAST, SILVA, and the Integrated Microbial Genomes (IMG) system provide extensive repositories of annotated metagenomic sequences, facilitating comparative studies and meta-analyses. These resources enable researchers to share data, standardize methodologies, and collaborate more effectively on a global scale. The continued expansion and refinement of bioinformatics tools and databases are expected to significantly enhance the capabilities of metagenomic research, driving further discoveries and applications across diverse scientific disciplines.

Metagenomics Market Segment Analysis:

Metagenomics Market Segmented based on Product, Technology, Workflow, and Application

By Product, Kits & Reagents Segment is Expected to Dominate the Market During the Forecast Period

• The Kits & Reagents segment is projected to dominate the global metagenomics market due to their essential role in sample preparation and the increasing demand for high-quality and reliable reagents in metagenomics workflows. Kits and reagents are fundamental to the metagenomics process as they provide the necessary components for DNA extraction, amplification, and library preparation. The growing adoption of metagenomic techniques in various fields, including clinical diagnostics and environmental monitoring, drives the demand for specialized kits and reagents that offer high precision and reproducibility. Furthermore, advancements in reagent formulations and the introduction of ready-to-use kits enhance the efficiency and ease of use, contributing to their widespread adoption.
• Additionally, the surge in research and development activities and the increasing number of metagenomics studies fuel the demand for kits and reagents. The ongoing expansion of personalized medicine and the need for accurate microbial profiling in clinical settings further boost the market growth. Companies are continuously investing in the development of innovative kits and reagents to cater to the evolving needs of researchers and clinicians, thereby ensuring the dominance of this segment in the metagenomics market during the forecast period.

By Technology, Shotgun Sequencing Segment Held the Largest Share

• The Shotgun Sequencing segment held the largest share of the metagenomics market due to its comprehensive and unbiased approach to analyzing complex microbial communities. Shotgun sequencing enables the identification and quantification of all genetic material present in a sample, providing a detailed snapshot of microbial diversity and function. This technology is particularly advantageous for studying environments with high microbial diversity, such as soil, marine ecosystems, and the human microbiome. Its ability to detect both known and unknown organisms makes it a preferred choice for metagenomics researchers.
• Moreover, the continuous advancements in sequencing technologies and the reduction in sequencing costs have made shotgun sequencing more accessible and cost-effective. The high-resolution data generated by shotgun sequencing is invaluable for applications in environmental monitoring, disease surveillance, and biotechnology. As researchers and industries increasingly recognize the benefits of comprehensive microbial analysis, the demand for shotgun sequencing is expected to remain strong, solidifying its leading position in the metagenomics market.

Metagenomics Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast Period

• North America is poised to lead the global metagenomics market due to its advanced healthcare infrastructure, significant investments in research and development, and a strong presence of key market players. The United States, in particular, has a well-established biotechnology sector and numerous academic and research institutions actively involved in metagenomics studies. This robust research environment facilitates continuous innovation and the development of cutting-edge metagenomics technologies, driving market growth in the region.
• Additionally, North America benefits from favorable government policies and substantial funding for genomics research. Initiatives such as the National Institutes of Health (NIH) and the Human Microbiome Project have provided extensive financial support and resources to accelerate metagenomics research. These programs not only enhance the understanding of microbial communities and their roles in health and disease but also promote the commercialization of metagenomics solutions. The strong regulatory framework in the region also ensures the safe and effective use of these technologies, further boosting market confidence and adoption.
• Furthermore, the rising prevalence of chronic diseases and the growing emphasis on precision medicine in North America contribute to the increasing demand for metagenomics. The ability to analyze complex microbial communities and their interactions with human hosts is crucial for developing targeted therapies and personalized treatment plans. As healthcare providers and researchers continue to recognize the value of metagenomics in disease prevention, diagnosis, and treatment, the market in North America is expected to witness sustained growth and maintain its dominant position over the forecast period.

Active Key Players in the Metagenomics Market

• Bio-Rad Laboratories Inc (United States)
• Illumina Inc (United States)
• PerkinElmer Inc (United States)
• Thermo Fisher Scientific Inc (United States)
• Novogene Co Ltd (China)
• Promega Corporation (United States)
• QIAGEN (Netherlands)
• Takara Bio Inc (Japan)
• Oxford Nanopore Technologies (United Kingdom)
• F. Hoffmann-La Roche Ltd (Switzerland) and Other Active Key Players

Chapter 1: Introduction
 1.1 Scope and Coverage

Chapter 2:Executive Summary

Chapter 3: Market Landscape
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Challenges
 3.2 Market Trend Analysis
 3.3 PESTLE Analysis
 3.4 Porter's Five Forces Analysis
 3.5 Industry Value Chain Analysis
 3.6 Ecosystem
 3.7 Regulatory Landscape
 3.8 Price Trend Analysis
 3.9 Patent Analysis
 3.10 Technology Evolution
 3.11 Investment Pockets
 3.12 Import-Export Analysis

Chapter 4: Metagenomics Market by Product
 4.1 Metagenomics Market Snapshot and Growth Engine
 4.2 Metagenomics Market Overview
 4.3 Kits & Reagents
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 Kits & Reagents: Geographic Segmentation Analysis
 4.4 Sequencing & Data Analytics Services
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 Sequencing & Data Analytics Services: Geographic Segmentation Analysis
 4.5 Software
  4.5.1 Introduction and Market Overview
  4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.5.3 Key Market Trends, Growth Factors and Opportunities
  4.5.4 Software: Geographic Segmentation Analysis

Chapter 5: Metagenomics Market by Technology
 5.1 Metagenomics Market Snapshot and Growth Engine
 5.2 Metagenomics Market Overview
 5.3 Shotgun Sequencing
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Shotgun Sequencing: Geographic Segmentation Analysis
 5.4 16S Sequencing
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 16S Sequencing: Geographic Segmentation Analysis
 5.5 Whole Genome Sequencing
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Whole Genome Sequencing: Geographic Segmentation Analysis
 5.6 Others
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Others: Geographic Segmentation Analysis

Chapter 6: Metagenomics Market by Workflow
 6.1 Metagenomics Market Snapshot and Growth Engine
 6.2 Metagenomics Market Overview
 6.3 Pre-sequencing
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Pre-sequencing: Geographic Segmentation Analysis
 6.4 Sequencing
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Sequencing: Geographic Segmentation Analysis
 6.5 Data Analysis
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Data Analysis: Geographic Segmentation Analysis

Chapter 7: Metagenomics Market by Application
 7.1 Metagenomics Market Snapshot and Growth Engine
 7.2 Metagenomics Market Overview
 7.3 Environmental
  7.3.1 Introduction and Market Overview
  7.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.3.3 Key Market Trends, Growth Factors and Opportunities
  7.3.4 Environmental: Geographic Segmentation Analysis
 7.4 Clinical Diagnostics
  7.4.1 Introduction and Market Overview
  7.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.4.3 Key Market Trends, Growth Factors and Opportunities
  7.4.4 Clinical Diagnostics: Geographic Segmentation Analysis
 7.5 Drug Discovery
  7.5.1 Introduction and Market Overview
  7.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.5.3 Key Market Trends, Growth Factors and Opportunities
  7.5.4 Drug Discovery: Geographic Segmentation Analysis
 7.6 Biotechnology
  7.6.1 Introduction and Market Overview
  7.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.6.3 Key Market Trends, Growth Factors and Opportunities
  7.6.4 Biotechnology: Geographic Segmentation Analysis
 7.7 Food & Nutrition
  7.7.1 Introduction and Market Overview
  7.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.7.3 Key Market Trends, Growth Factors and Opportunities
  7.7.4 Food & Nutrition: Geographic Segmentation Analysis
 7.8 Others
  7.8.1 Introduction and Market Overview
  7.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.8.3 Key Market Trends, Growth Factors and Opportunities
  7.8.4 Others: Geographic Segmentation Analysis

Chapter 8: Company Profiles and Competitive Analysis
 8.1 Competitive Landscape
  8.1.1 Competitive Benchmarking
  8.1.2 Metagenomics Market Share by Manufacturer (2023)
  8.1.3 Industry BCG Matrix
  8.1.4 Heat Map Analysis
  8.1.5 Mergers and Acquisitions
  
 8.2 BIO-RAD LABORATORIES INC (UNITED STATES)
  8.2.1 Company Overview
  8.2.2 Key Executives
  8.2.3 Company Snapshot
  8.2.4 Role of the Company in the Market
  8.2.5 Sustainability and Social Responsibility
  8.2.6 Operating Business Segments
  8.2.7 Product Portfolio
  8.2.8 Business Performance
  8.2.9 Key Strategic Moves and Recent Developments
  8.2.10 SWOT Analysis
 8.3 ILLUMINA INC (UNITED STATES)
 8.4 PERKINELMER INC (UNITED STATES)
 8.5 THERMO FISHER SCIENTIFIC INC (UNITED STATES)
 8.6 NOVOGENE CO LTD (CHINA)
 8.7 PROMEGA CORPORATION (UNITED STATES)
 8.8 QIAGEN (NETHERLANDS)
 8.9 TAKARA BIO INC (JAPAN)
 8.10 OXFORD NANOPORE TECHNOLOGIES (UNITED KINGDOM)
 8.11 F. HOFFMANN-LA ROCHE LTD (SWITZERLAND)
 8.12 OTHER KEY PLAYERS

Chapter 9: Global Metagenomics Market By Region
 9.1 Overview
 9.2. North America Metagenomics Market
  9.2.1 Key Market Trends, Growth Factors and Opportunities
  9.2.2 Top Key Companies
  9.2.3 Historic and Forecasted Market Size by Segments
  9.2.4 Historic and Forecasted Market Size By Product
   9.2.4.1 Kits & Reagents
   9.2.4.2 Sequencing & Data Analytics Services
   9.2.4.3 Software
  9.2.5 Historic and Forecasted Market Size By Technology
   9.2.5.1 Shotgun Sequencing
   9.2.5.2 16S Sequencing
   9.2.5.3 Whole Genome Sequencing
   9.2.5.4 Others
  9.2.6 Historic and Forecasted Market Size By Workflow
   9.2.6.1 Pre-sequencing
   9.2.6.2 Sequencing
   9.2.6.3 Data Analysis
  9.2.7 Historic and Forecasted Market Size By Application
   9.2.7.1 Environmental
   9.2.7.2 Clinical Diagnostics
   9.2.7.3 Drug Discovery
   9.2.7.4 Biotechnology
   9.2.7.5 Food & Nutrition
   9.2.7.6 Others
  9.2.8 Historic and Forecast Market Size by Country
   9.2.8.1 US
   9.2.8.2 Canada
   9.2.8.3 Mexico
 9.3. Eastern Europe Metagenomics Market
  9.3.1 Key Market Trends, Growth Factors and Opportunities
  9.3.2 Top Key Companies
  9.3.3 Historic and Forecasted Market Size by Segments
  9.3.4 Historic and Forecasted Market Size By Product
   9.3.4.1 Kits & Reagents
   9.3.4.2 Sequencing & Data Analytics Services
   9.3.4.3 Software
  9.3.5 Historic and Forecasted Market Size By Technology
   9.3.5.1 Shotgun Sequencing
   9.3.5.2 16S Sequencing
   9.3.5.3 Whole Genome Sequencing
   9.3.5.4 Others
  9.3.6 Historic and Forecasted Market Size By Workflow
   9.3.6.1 Pre-sequencing
   9.3.6.2 Sequencing
   9.3.6.3 Data Analysis
  9.3.7 Historic and Forecasted Market Size By Application
   9.3.7.1 Environmental
   9.3.7.2 Clinical Diagnostics
   9.3.7.3 Drug Discovery
   9.3.7.4 Biotechnology
   9.3.7.5 Food & Nutrition
   9.3.7.6 Others
  9.3.8 Historic and Forecast Market Size by Country
   9.3.8.1 Bulgaria
   9.3.8.2 The Czech Republic
   9.3.8.3 Hungary
   9.3.8.4 Poland
   9.3.8.5 Romania
   9.3.8.6 Rest of Eastern Europe
 9.4. Western Europe Metagenomics Market
  9.4.1 Key Market Trends, Growth Factors and Opportunities
  9.4.2 Top Key Companies
  9.4.3 Historic and Forecasted Market Size by Segments
  9.4.4 Historic and Forecasted Market Size By Product
   9.4.4.1 Kits & Reagents
   9.4.4.2 Sequencing & Data Analytics Services
   9.4.4.3 Software
  9.4.5 Historic and Forecasted Market Size By Technology
   9.4.5.1 Shotgun Sequencing
   9.4.5.2 16S Sequencing
   9.4.5.3 Whole Genome Sequencing
   9.4.5.4 Others
  9.4.6 Historic and Forecasted Market Size By Workflow
   9.4.6.1 Pre-sequencing
   9.4.6.2 Sequencing
   9.4.6.3 Data Analysis
  9.4.7 Historic and Forecasted Market Size By Application
   9.4.7.1 Environmental
   9.4.7.2 Clinical Diagnostics
   9.4.7.3 Drug Discovery
   9.4.7.4 Biotechnology
   9.4.7.5 Food & Nutrition
   9.4.7.6 Others
  9.4.8 Historic and Forecast Market Size by Country
   9.4.8.1 Germany
   9.4.8.2 UK
   9.4.8.3 France
   9.4.8.4 Netherlands
   9.4.8.5 Italy
   9.4.8.6 Russia
   9.4.8.7 Spain
   9.4.8.8 Rest of Western Europe
 9.5. Asia Pacific Metagenomics Market
  9.5.1 Key Market Trends, Growth Factors and Opportunities
  9.5.2 Top Key Companies
  9.5.3 Historic and Forecasted Market Size by Segments
  9.5.4 Historic and Forecasted Market Size By Product
   9.5.4.1 Kits & Reagents
   9.5.4.2 Sequencing & Data Analytics Services
   9.5.4.3 Software
  9.5.5 Historic and Forecasted Market Size By Technology
   9.5.5.1 Shotgun Sequencing
   9.5.5.2 16S Sequencing
   9.5.5.3 Whole Genome Sequencing
   9.5.5.4 Others
  9.5.6 Historic and Forecasted Market Size By Workflow
   9.5.6.1 Pre-sequencing
   9.5.6.2 Sequencing
   9.5.6.3 Data Analysis
  9.5.7 Historic and Forecasted Market Size By Application
   9.5.7.1 Environmental
   9.5.7.2 Clinical Diagnostics
   9.5.7.3 Drug Discovery
   9.5.7.4 Biotechnology
   9.5.7.5 Food & Nutrition
   9.5.7.6 Others
  9.5.8 Historic and Forecast Market Size by Country
   9.5.8.1 China
   9.5.8.2 India
   9.5.8.3 Japan
   9.5.8.4 South Korea
   9.5.8.5 Malaysia
   9.5.8.6 Thailand
   9.5.8.7 Vietnam
   9.5.8.8 The Philippines
   9.5.8.9 Australia
   9.5.8.10 New Zealand
   9.5.8.11 Rest of APAC
 9.6. Middle East & Africa Metagenomics Market
  9.6.1 Key Market Trends, Growth Factors and Opportunities
  9.6.2 Top Key Companies
  9.6.3 Historic and Forecasted Market Size by Segments
  9.6.4 Historic and Forecasted Market Size By Product
   9.6.4.1 Kits & Reagents
   9.6.4.2 Sequencing & Data Analytics Services
   9.6.4.3 Software
  9.6.5 Historic and Forecasted Market Size By Technology
   9.6.5.1 Shotgun Sequencing
   9.6.5.2 16S Sequencing
   9.6.5.3 Whole Genome Sequencing
   9.6.5.4 Others
  9.6.6 Historic and Forecasted Market Size By Workflow
   9.6.6.1 Pre-sequencing
   9.6.6.2 Sequencing
   9.6.6.3 Data Analysis
  9.6.7 Historic and Forecasted Market Size By Application
   9.6.7.1 Environmental
   9.6.7.2 Clinical Diagnostics
   9.6.7.3 Drug Discovery
   9.6.7.4 Biotechnology
   9.6.7.5 Food & Nutrition
   9.6.7.6 Others
  9.6.8 Historic and Forecast Market Size by Country
   9.6.8.1 Turkey
   9.6.8.2 Bahrain
   9.6.8.3 Kuwait
   9.6.8.4 Saudi Arabia
   9.6.8.5 Qatar
   9.6.8.6 UAE
   9.6.8.7 Israel
   9.6.8.8 South Africa
 9.7. South America Metagenomics Market
  9.7.1 Key Market Trends, Growth Factors and Opportunities
  9.7.2 Top Key Companies
  9.7.3 Historic and Forecasted Market Size by Segments
  9.7.4 Historic and Forecasted Market Size By Product
   9.7.4.1 Kits & Reagents
   9.7.4.2 Sequencing & Data Analytics Services
   9.7.4.3 Software
  9.7.5 Historic and Forecasted Market Size By Technology
   9.7.5.1 Shotgun Sequencing
   9.7.5.2 16S Sequencing
   9.7.5.3 Whole Genome Sequencing
   9.7.5.4 Others
  9.7.6 Historic and Forecasted Market Size By Workflow
   9.7.6.1 Pre-sequencing
   9.7.6.2 Sequencing
   9.7.6.3 Data Analysis
  9.7.7 Historic and Forecasted Market Size By Application
   9.7.7.1 Environmental
   9.7.7.2 Clinical Diagnostics
   9.7.7.3 Drug Discovery
   9.7.7.4 Biotechnology
   9.7.7.5 Food & Nutrition
   9.7.7.6 Others
  9.7.8 Historic and Forecast Market Size by Country
   9.7.8.1 Brazil
   9.7.8.2 Argentina
   9.7.8.3 Rest of SA

Chapter 10 Analyst Viewpoint and Conclusion
10.1 Recommendations and Concluding Analysis
10.2 Potential Market Strategies

Chapter 11 Research Methodology
11.1 Research Process
11.2 Primary Research
11.3 Secondary Research